Related Site
2005 Events
Innovations in Improving Access to Health Care: Appropriate and Feasible?
Stanford's Fourth Annual Conference on International Development
presented by The Stanford Association for International Development and the International Development Club Stanford, GSB
co-sponsored by: the ASSU & GSB Global Management Program
|
|
Shortages of Health Services, Abundance of Red Tape Hamper AIDS/HIV Battle
Insufficient coordination of health-care resources in developing countries—not simply a shortage of funding—is the primary reason the incidence of HIV/AIDS is still so high, particularly in Africa, speakers told the fourth annual Stanford Conference on International Development on February 26. "It's true that we haven't had adequate resources to address this epidemic," said keynote speaker Debrework Zewdie, director of the Global AIDS/HIV Program at the World Bank. "But it is impossible to use resources effectively if we pull countries in too many different directions," she explained.
Article
Funding Innovations Panel
Donor spending targeting infectious diseases has skyrocketed in recent years. The increased spending also begets. Panelists iscussed how their organizations fits into the landscape of donors and shared lessons on how they addressed challenges of increased scrutiny around project priorities, speed of disbursement and implementation, project effectiveness and long-run sustainability. Panelists discussed the changing landscape and promising techniques and models.
Text of Panel Discussion
Donovan Cook, Moderator, Associate Professor, UCSF
Timothy Goodman, Assistant Director for Global Policy, Pfizer IncSrividya Prakash, Global Health Group, McKinsey & Company, San Francisco
David Green, CEO, Project Impact, Berkeley, CA
Delivery Innovations Panel
Medical innovations have already made life-saving treatments for HIV/AIDS, TB and malaria available to people with access to well-resourced medical systems. Unfortunately, despite substantial reductions in pricing, society has yet to succeed in providing large-scale access to these medicines to those most in need. The panelists will discuss the main challenges preventing broader adoption of these therapies, share lessons learned from public-private partnerships tackling these challenges. The panelists will also predict future innovations in delivery and the conditions necessary to make this future a reality.
Text of Panel Discussion
Judith Justice, Moderator, Associate Professor, UCSF
Ophelia Dahl, President and Executive Director, Partners in Health
Jack Higgins, Digital Vision Fellow, Global Telemedicine Project
Vikram Kumar, Director, Dimagi (handheld computer technology)
Tony Carroll, Consultant to Merck
Medical Innovations Panel
Infectious diseases now account for only one out of 10 deaths in the world's richest countries, but among the world's poorest people, six in 10 die of infectious diseases, according to the World Health Organization
(WHO). Half of these deaths could be prevented. Further, more than US $70 billion is spent worldwide on health research and development by the public and private sectors every year, according to the Global Forum for Health Research. An estimated 10% is used for research into 90% of the world's health problems. Called "the 10/90 gap", the consequences of this inequity are visible around the world.Text of Panel Discussion
Phyllis Gardner, Moderator, Associate Professor Stanford University Medical School
Douglas Holtzman, Program Officer Infectious Diseases, Bill and Melinda Gates Foundation
George Rutherford, Interim director UCSF Institute for Global Health
Katherine Woo, Director Scientific Affairs, One World Health
Nzeera Ketter, Director Efficacy Trials, International AIDS Vaccine Initiative
